20020 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
METHOD OF TREATING CANCER
#3302LIPOSOMES ENCAPSULATING ADENOSINE
#3303LIPOSOMAL OZONE NANOSOLUTIONS
#3304DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS
#3305Treatments for benign prostatic hyperplasia
#3306SUBCUTANEOUS ABSORPTION AND BIOAVAILABILITY OF ANTIBODIES
#3307MICROFLUIDIC LASER-ACTIVATED INTRACELLULAR DELIVERY SYSTEMS AND METHODS
#3308MONO- AND MULTI-VALENT SARS-COV- 2 ADENOVIRAL VECTOR VACCINES AND SARS-COV-2 IMMUNE GLOBULIN AND METHODS OF USE
#3309COMBINATION THERAPY USING A LIV1-ADC AND A CHEMOTHERAPEUTIC
#3310METHOD OF TREATMENT USING ANTI-CCL24 ANTIBODY
#3311PRODUCTION OF RECOMBINANT LUBRICIN
#3312NANOBODY (VHH) CONJUGATES AND USES THERE OF
#3313COMPOSITIONS AND METHODS FOR TREATING ANAL HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESION (HSIL)
#3314Formulation of a peptide vaccine
#3315USE OF AN INHIBITOR OF ACTIN REMODELING MODULATOR FOR THE MANUFACTURE OF A MEDICAMENT FOR TREATMENT OF SLEEP DEPRIVATION-INDUCED MEMORY DEFICIT
#3316PHARMACEUTICAL COMPOSITION FOR TREATING CHRONIC STROKE
#3317REGULATORY MACROPHAGES FOR TREATING ANGIOPATHIES
#3318Compositions and Methods for Suppressing MSUT2
#3319COMPOUNDS AND METHODS FOR TREATING FUNGAL INFECTIONS
#3320USE OF NERIDRONIC ACID OR OF ITS SALT FOR THE TREATMENT OF OSTEOARTHROSIS
#3321Abiraterone prodrugs
#3322TREATING INFLUENZA USING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF
#3323USE OF PHOSPHODIESTERASE 5 INHIBITOR IN PREPARATION OF MEDICAMENT FOR RESISTING FIBROTIC DISEASES
#3324COMPOSITIONS AND METHODS FOR TREATMENT
#3325COMPOSITIONS AND METHODS FOR INTRAVENOUS ADMINISTRATION OF 2-BROMO-1-(3,3-DINITROAZETIDIN-1-YL)ETHANONE
#3326Extended Duration Local Anesthetic Formulation
#3327Pharmacological prophylactics against stress-induced affective disorders in females
#3328Methods of permeabilizing the blood brain barrier
#3329LIPID NANOPARTICLES CONTAINING POLYNUCLEOTIDES ENCODING GLUCOSE-6-PHOSPHATASE AND USES THEREOF
#3330SYNERGISTIC ANTI-VIRAL PHARMACEUTICAL COMPOSITION CONTAINING TARGETING NANOPARTICLES
#3331AMBRISENTAN FOR USE IN THE TREATMENT OF ACUTE RENAL FAILURE
#3332SUXAMETHONIUM COMPOSITION AND PREFILLED SYRINGE THEREOF
#3333METHOD OF USING HUMAN SPHEROIDS FOR DRUG DISCOVERY
#3334GENETICALLY MODIFIED MESENCHYMAL STEM CELLS EXPRESSING ALPHA-1 ANTITRYPSIN (AAT)
#3335Polynucleotides encoding antibodies which bind the EC3 domain of cadherin-6 (CDH6) and possess internalization ability
#3336Saposin C pharmaceutical compositions and methods of treating cancer
#3337METHODS AND COMPOSITIONS FOR INDUCING FERROPTOSIS IN VIVO
#3338ANTI-ANGIOGENESIS THERAPY FOR THE TREATMENT OF OVARIAN CANCER
#3339HIGHLY CONCENTRATED LOW VISCOSITY MASP-2 INHIBITORY ANTIBODY FORMULATIONS, KITS, AND METHODS
#3340LOW-VISCOSITY, HIGH CONCENTRATION EVOLOCUMAB FORMULATIONS AND METHODS OF MAKING THE SAME
#3341Mutant Peptides And Methods Of Treating Subjects Using The Same
#3342ANGIOTENSIN II ALONE OR IN COMBINATION FOR THE TREATMENT OF HYPOTENSION
#3343HUMAN FACILITATING CELLS
#3344COMPOSITION
#3345Hydroxypropyl beta-cyclodextrin compositions and methods
#3346Hydroxypropyl beta-cyclodextrin compositions and methods
#3347ADENOSINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
#3348Injectable antibiotic formulations and use thereof
#3349ANIMAL STERILIZATION BY ESTROGENIC COMPOUNDS
#3350METHYLENE BLUE AND RIBOFLAVIN FOR PROPHYLACTIC AND THERAPEUTIC ANTI-VIRAL THERAPY
#3351Trabectedin composition
#3352METHODS OF TREATING A CORONAVIRUS INFECTION
#3353METHODS OF ADMINISTERING SOTALOL HYDROCHLORIDE
#3354METHODS OF ADMINISTERING AN ARIPIPRAZOLE INJECTABLE PREPARATION
#3355Methods, Parenteral Pharmaceutical Formulations, and Devices for the Prevention of Opioid Overdose
#3356Method of Administering Sotalol IV/SWITCH
#3357GENE-ENGINEERED MESENCHYMAL STEM CELLS AND APPLICATIONS THEREOF
#3358Anti-Blys Antibody for Treating Proteinuric Kidney Disease
#3359COMPOSITIONS AND METHODS FOR TREATMENT OF GENE THERAPY PATIENTS
#3360IL-1BETA BINDING ANTIBODIES FOR USE IN TREATING CANCER
#3361T-cell modulatory multimeric polypeptides and methods of use thereof
#3362Compositions for Treatment of Vascular Disease
#3363TREATMENT WITH ANTI-VEGF ANTIBODIES
#3364VACCINE COMPOSITIONS, METHODS, AND USES THEREOF
#3365Bortezomib compositions
#3366PHARMACEUTICAL AQUEOUS FORMULATION COMPRISING 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-DIMORPHOLIN-4-YL-1,3,5-TRIAZIN-2-YL)PHENYL]UREA
#3367Analgesic formulations and methods for reduced postoperative nausea and vomiting and enhanced postoperative pain relief
#3368Analgesic formulations and methods for reduced postoperative nausea and vomiting and enhanced postoperative pain relief
#3369THERAPEUTIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USE THEREOF
#3370Combinations of β-lactam compounds and probenecid and uses thereof
#3371COMPOSITIONS AND METHODS COMPRISING DENDRIMERS AND THERAPEUTIC AGENTS
#3372Peptide pharmaceuticals for treatment of NASH and other disorders
#3373CHEMICAL COMPOSITION
#3374MEDICAMENT FOR TREATING HYPERTENSION
#3375TREATMENT OF SCHIZOPHRENIA USING BETA-CARYOPHYLLENE AND CB2 RECEPTOR AGONISTS
#3376TARGETING THE INNATE IMMUNE SYSTEM TO INDUCE LONG-TERM TOLERANCE AND TO RESOLVE MACROPHAGE ACCUMULATION IN ATHEROSCLEROSIS
#3377Non-naturally occurring vesicles comprising a chimeric vesicle localization moiety, methods of making and uses thereof
#3378IMMUNOMODULATING TREATMENTS OF BODY CAVITIES
#3379METHODS FOR ADMINISTERING ARIPIPRAZOLE
#3380ARTIFICIAL EXPRESSION CONSTRUCTS FOR SELECTIVELY MODULATING GENE EXPRESSION IN INHIBITORY NEOCORTICAL NEURONS
#3381PH20 polypeptide variants, formulations and uses thereof
#3382PLATFORM FOR GENERATING SAFE CELL THERAPEUTICS
#3383Carbohydrate crosslinker
#3384EARLY INTERVENTION METHODS TO PREVENT OR AMELIORATE TOXICITY
#3385METHODS AND COMPOSITIONS FOR TREATING, PREVENTING THE ONSET AND/OR SLOWING PROGRESSION OF OSTEOARTHRITIS
#3386PEPTIDE COMPOSTIONS AND METHODS FOR TREATING TAUOPATHIES
#3387STAT3 DEGRADERS AND USES THEREOF
#3388SOLID FORMS OF 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE, AND THEIR PHARMACEUTICAL COMPOSITIONS AND USES
#3389AAV Gene Therapy for Spastic Paraplegia
#3390Treatments for retinal disease
#3391HETEROLOGOUS COMBINATION PRIME:BOOST THERAPY AND METHODS OF TREATMENT
#3392INJECTABLE BOTULINUM TOXIN METHOS FOR TREATING HEADACHES
#3393PHARMACEUTICAL COMPOSITION IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION INCLUDING AT LEAST A RAPID ACTING INSULIN ANALOG AND A GLUCAGON SUPPRESSOR WITH PRANDIAL ACTION
#3394Ready-to-use bivalirudin compositions
#3395METHODS AND MATERIALS FOR TREATING NON-MALIGNANT DISORDERS OR DISEASES WITH CORD BLOOD
#3396Methods of Treating, Reducing the Incidence of, and/or Preventing Ischemic Events
#3397Formulations and methods for treating conditions of the eye
#3398FORMULATIONS OF BRINCIDOFOVIR
#3399RESPIRATORY STIMULANT PARENTERAL FORMULATIONS
#3400METHOD FOR RAPID INFUSION OF CARMUSTINE
#3401GEL FOR USE IN GASTROINTESTINAL ENDOSCOPY AND ENDODERMAL, EPIDERMAL, AND OTHER MUCOSAL USES
#3402EPINEPHRINE PREMIX FORMULATIONS AND USES THEREOF
#3403In vivo targeting of Fibrosis by anti-CD5-targeted FAP-CAR T mRNA-LNP
#3404GENETIC MODIFICATION OF MAMMALIAN CELLS TO CONFER RESISTANCE TO CSF1R ANTAGONISTS
#3405Treatment of diabetes mellitus
#3406Pharmaceutical composition of a humanized anti-CD40 antibody
#3407ANTI-CTLA-4 MONOCLONAL ANTIBODY, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#3408TREATMENT OF ATOPIC DERMATITIS
#3409METHODS OF TREATING AN ALLERGY WITH ALLERGEN-SPECIFIC MONOCLONAL ANTIBODIES
#3410COMPOSITIONS INCLUDING MULTI-AGONIST PEPTIDES AND METHODS OF MANUFACTURE AND USE
#3411CYCLOPHILIN INHIBITORS AND USES THEREOF
#3412BIOMEDICAL IMAGING OF BACTERIA AND VIRUSES
#3413GENE THERAPY AND TARGETED DELIVERY OF CONJUGATED COMPOUNDS
#3414Layer-by-layer nanoparticles for cytokine therapy in cancer treatment
#3415CARBON NANOTUBES AND COMPLEXES THEREOF FOR TREATING AND DETECTING OCULAR TUMORS
#3416ANHYDROUS SODIUM THIOSULFATE AND FORMULATIONS THEREOF
#3417ANHYDROUS SODIUM THIOSULFATE AND FORMULATIONS THEREOF
#3418ANHYDROUS SODIUM THIOSULFATE AND FORMULATIONS THEREOF
#3419MIMOTOPES OF ALPHA-SYNUCLEIN AND VACCINES THEREOF FOR THE TREATMENT OF SYNUCLEINOPATHY
#3420METHODS FOR TREATING HYPOPHOSPHATASIA IN CHILDREN AND ADOLESCENTS
#3421TNAP LOCALLY ADMINISTERED FOR PROMOTING PERIODONTAL HEALTH
#3422PHARMACEUTICAL COMPOSITION IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION INCLUDING AT LEAST A RAPID-ACTING INSULIN ANALOG AND A GLUCAGON SUPPRESSOR WITH PRANDIAL ACTION
#3423METHODS FOR TREATING PANCREATIC CANCER AND OTHER SOLID TUMORS
#3424METHODS FOR THE PREVENTION AND TREATMENT OF BURN INJURIES AND SECONDARY COMPLICATIONS
#3425AQUEOUS EXTRACTION PROCESS OF PLANTS, METHOD THEREOF, AND PRODUCT BY PROCESS
#3426CELL-BASED THERAPIES AND USES THEREOF
#3427FIBROBLAST THERAPY FOR PREVENTION AND REVERSION OF ANEURYSMS
#3428Hydroxypropyl beta-cyclodextrin compositions and methods
#3429Methods of Treating Residual Lesions of Vascular Anomalies
#3430LPXC INHIBITOR, FORMULATIONS, AND USES THEREOF
#3431COMBINATIONS OF ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND CHEMOTHERAPEUTIC AGENTS, AND METHODS OF USE
#3432Treating extrapyramidal syndrome using trapidil
#3433METHODS OF TREATMENT USING ANTIFOLATES AND PHARMACEUTICAL FORMULATIONS COMPRISING ANTIFOLATES
#3434THERAPEUTIC DRUG FOR DYSKINESIA
#3435PHARMACEUTICAL FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION OF FUROSEMIDE
#3436USES OF ORNITHINE PHENYLACETATE FOR TREATING HYPERAMMONEMIA
#3437Compositions and methods of administering baclofen
#3438COMPOSITIONS AND METHODS FOR TREATMENT OF INHERITED MACULAR DEGENERATION
#3439PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR TREATING PEDIATRIC HEREDITARY ANGIOEDEMA ATTACK
#3440OPTIMIZED ANTI-TL1A ANTIBODIES
#3441Influenza virus replication for vaccine development
#3442Compositions and methods for treating CNS disorders
#3443THERAPEUTIC AGENT FOR BLOOD CANCER
#3444Spiro-lactam NMDA modulators and methods of using same
#3445Substituted antivirals for treating coronavirus infection
#3446Codon optimized GLA genes and uses thereof
#3447Recombinant MVA Viruses for Intratumoral and/or Intravenous Administration for Treating Cancer
#3448Methods for treating pulmonary disease using inter-alpha inhibitor proteins
#3449LIQUID NEUROTOXIN FORMULATION STABILIZED WITH TRYPTOPHAN OR TYROSINE
#3450METHOD AND DRUG FOR TREATING SPINAL MUSCULAR ATROPHY
#3451SUBCUTANEOUS ADMINISTRATION OF FACTOR VIII
#3452Formulations of Human Parathyroid Hormone (PTH) and Methods for Producing Same
#3453PURIFIED AMPHIPHILIC PEPTIDE COMPOSITIONS AND USES THEREOF
#3454GENE THERAPY FOR TREATING FAMILIAL HYPERCHOLESTEROLEMIA
#3455Continuous release compositions made from hyaluronic acid, and therapeutic applications of same
#3456METHYLENE BLUE STABILIZED MRNA COMPOSITIONS
#3457COMPOSITIONS AND METHODS FOR THE TREATMENT OF A BETA-CATENIN-ASSOCIATED DISEASE OR DISORDER
#3458Stable liquid compositions of netupitant and palonosetron
#3459Methods and compositions for treating cancer
#3460FORMULATIONS OF DOCETAXEL
#3461STABLE DIGLYCERIDE EMULSIONS AND METHODS FOR TREATING ORGAN INJURY
#3462FORMULATIONS OF VASOPRESSIN
#3463Anti-CD37 immunoconjugate and anti-CD20 antibody combinations
#3464ANTIBODY AND PROTEIN FORMULATIONS
#3465Compositions and methods to detect gastrointestinal disease
#3466COMPLEXES FOR GENE DELETION AND EDITING
#3467Particle delivery systems
#3468THERAPEUTIC USE OF MITOCHONDRIA AND COMBINED MITOCHONDRIAL AGENTS
#3469STEM CELL IMMUNOMODULATORY THERAPY FOR COVID-19 INFECTION
#3470PHARMACEUTICAL COMPOSITIONS OF HUMANIZED ANTI-CD40 ANTIBODIES AND USES THEREOF
#3471Subcutaneously administered anti-IL-6 receptor antibody
#3472EXTENDED LOCAL RELEASE OF ANTIBODIES
#3473STABLE ANTIBODY FORMULATION
#3474THERAPEUTIC ANTIBODY FORMULATION
#3475FC-REGION VARIANTS WITH IMPROVED PROTEIN A-BINDING
#3476RCOM PROTEIN BASED CARBON MONOXIDE SCAVENGERS AND PREPARATIONS FOR THE TREATMENT OF CARBON MONOXIDE POISONING
#3477STRUCTURALLY-STABILIZED GLUCAGON-LIKE PEPTIDE 1 PEPTIDES AND USES THEREOF
#3478Sodium thiosulfate-containing pharmaceutical compositions
#3479COMPOSITIONS AND METHODS OF TARGETING AND IMAGING AGED MICROGLIA WITH Aß PEPTIDE AMINO ACID RESIDUES FOR V-DOMAIN BINDING OF RAGE
#3480CCR7 ANTIBODY DRUG CONJUGATES FOR TREATING CANCER
#3481STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES
#3482COMBINATIONS OF IMMUNOTHERAPIES AND USES THEREOF
#3483METHODS OF TREATING INFECTIONS
#3484LIQUID NEUROTOXIN FORMULATION STABILIZED WITH TRYPTOPHAN OR TYROSINE
#3485METHOD AND DRUG FOR TREATING SPINAL MUSCULAR ATROPHY
#3486PLATELET FACTORS AND COGNITIVE IMPROVEMENT
#3487SINGLE DOSE METHODS FOR PREVENTING AND TREATING FUNGAL INFECTIONS
#3488NOVEL FORMUATIONS
#3489TREATMENT OF VIRUS-INDUCED ACUTE RESPIRATORY DISTRESS SYNDROME
#3490INJECTABLE NEUROSTEROID FORMULATIONS CONTAINING NANOPARTICLES
#3491Organic compounds
#3492Liposomes Useful for Drug Delivery
#3493DOSING REGIMENS FOR USE IN TREATING RELAPSED AND REFRACTORY MULTIPLE MYELOMA WITH VENETOCLAX
#3494PANOBINOSTAT DOSAGES FOR MULTIPLE MYELOMA
#3495Methods of efficiently treating vitamin C deficiency-related diseases and other conditions
#3496Ready-to-use ascorbic acid compound compositions
#3497THE USE OF DIFFUSION ENHANCING COMPOUNDS FOR TREATMENT OF VIRAL AND BACTERIAL INDUCED RESPIRATORY DISEASE
#3498Aqueous formulation comprising paracetamol and ibuprofen
#3499IMPROVED MRNA-LOADED LIPID NANOPARTICLES AND PROCESSES OF MAKING THE SAME
#3500CONCENTRATED COMPOSITIONS OF PROTEINS, THEIR PREPARATION AND USE THEREOF
#3501DRUG-LOADED BIODEGRADABLE MICROBEAD COMPOSITIONS INCLUDING DRUG-CONTAINING VESICULAR AGENTS
#3502COMPOSITIONS AND USES OF ALPHA-ADRENERGIC AGENTS
#3503MODIFIED PEPTIDE NUCLEIC ACID COMPOSITIONS
#3504Carboxyalkyl Chitosan
#3505Compositions and Methods For Blood-Brain Barrier Delivery
#3506METHODS AND COMPOSITIONS FOR TREATING DISEASES AND DISORDERS OF THE NERVOUS SYSTEM
#3507PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING BEHCET'S DISEASE AND RHEUMATOID ARTHRITIS, CONTAINING PEPTIDE OR MIXTURE THEREOF AS ACTIVE INGREDIENT
#3508Compounds useful in HIV therapy
#3509ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF MICRO-DYSTROPHIN TO TREAT MUSCULAR DYSTROPHY
#3510BIOCOMPATIBLE MATERIAL AND METHODS FOR MAKING AND USING THE SAME
#3511NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS
#3512USE OF POLYPHENOL CONTAINING SUGAR CANE EXTRACTS FOR PREVENTING, IMPROVING OR TREATING A SKIN CONDITION
#3513CONTROLLED RELEASE HYALURONIC ACID COMPOSITIONS
#3514ETHANOLAMINE-BASED LIPID BIOSYNTHETIC COMPOUNDS, METHOD OF MAKING AND USE THEREOF
#3515Physiologically balanced injectable formulations of fosnetupitant
#3516METHODS FOR SOLID TUMOR TREATMENT
#3517AN INSULIN SENSITIZER FOR USE IN THE PREVENTION AND/OR TREATMENT OF THE DAMAGES CAUSED BY RETINAL DETACHMENT
#3518ANTI-ARRHYTHMIC COMPOSITIONS AND METHODS
#3519DRUG-LOADED MICROBEAD COMPOSITIONS, EMBOLIZATION COMPOSITIONS AND ASSOCIATED METHODS
#3520EPHEDRINE LIQUID FORMULATIONS
#3521Treatment of Multiple Sclerosis with Anti-CD52 Antibodies
#3522High concentration antibody-containing liquid formulation
#3523COMPOSITIONS COMPRISING ANTI-VEGF AND NANOPARTICLES AND METHODS OF USING THE SAME FOR THE TREATMENT OF ABNORMAL OR EXCESSIVE ANGIOGENESIS
#3524Ergoline analogues
#3525DELIVERY DEVICE FOR HEMOSTATIC COMPOSITIONS
#3526[161Tb]-BASED RADIOPEPTIDES
#3527COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA
#3528Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
#3529Pre-Mixed, Ready-To-Use Pharmaceutical Compositions
#3530Antibody compositions
#3531Precision Dosing Regimen
#3532IMMUNOGENIC COMPOSITION COMPRISING CYAA-DERIVED POLYPEPTIDE PROMOTING A TH1/TH17-ORIENTED IMMUNE RESPONSE
#3533BOTULINUM TOXIN PRE-FILLED INJECTABLE FORMULATION THAT FACILITATES DISCHARGE RATE CONTROL AND IS STABLE
#3534CNS DELIVERY OF THERAPEUTIC AGENTS
#3535MEDICAMENT FOR THERAPEUTIC TREATMENT AND/OR IMPROVEMENT OF SEPSIS ACCOMPANIED BY COAGULOPATHY
#3536A PREPARATION FOR PERIODONTAL TISSUE AND A KIT COMPRISING THE SAME
#3537Use of pridopidine for treating rett syndrome
#3538TREATMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH ANTI-PROLIFERATE AND ANTI-INFLAMMATORY DRUGS
#3539INTRAVENOUS FORMULATIONS OF COENZYME Q10 (CoQ10) AND METHODS OF USE THEREOF
#3540TREATING MICROVASCULAR DYSFUNCTION
#3541Novel Method For Producing Low Viscous And Highly Concentrated Biopharmaceutical Drug Products In Liquid Formulation
#3542Controlled Exposure to Pathogens for Generating Immunity
#3543PLATFORM FOR GENERATING SAFE CELL THERAPEUTICS
#3544Compounds as GLP-1R agonists
#3545Perfusion system
#3546Formulations and methods for direct sodium removal in patients having heart failure and/or severe renal dysfunction
#3547METHODS AND SYSTEMS FOR NONINVASIVE CONTROL OF BRAIN CELLS AND RELATED VECTORS AND COMPOSITIONS
#3548METHOD FOR ENHANCING CELLULAR IMMUNOTHERAPY
#3549STIMULI RESPONSIVE BLOCK COPOLYMERS
#3550Therapeutic uses for sodium thiosulfate formulations
#3551CGRP ANTAGONISTS AND CLOSTRIDIAL DERIVATIVES FOR THE TREATMENT OF NEUROPSYCHIATRIC AND NEUROLOGICAL DISORDERS
#3552COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES
#3553Use of bremelanotide in patients with controlled hypertension
#3554USE OF HUMAN AMYLIN ANALOG POLYPEPTIDES FOR PROVIDING SUPERIOR GLYCEMIC CONTROL TO TYPE 1 DIABETICS
#3555USE OF CD83 IN COMBINATION THERAPIES
#3556Glycopeptide compositions
#3557STABLE READY TO DILUTE FORMULATIONS OF CARFILZOMIB
#3558Nanotherapy Targeting RHAMM-Positive Tumors
#3559COMPOSITIONS AND METHODS FOR THE TREATMENT OF PAIN
#3560PHARMACEUTICAL PREPARATION FOR IMPROVING ABSORPTION AND POSTPRANDIAL HYPOGLYCEMIC ACTION OF INSULIN
#3561DRUG COMBINATIONS FOR INHIBITING INFLAMMATION AND SRC KINASE ACTIVATION FOLLOWING INVASIVE SURGICAL PROCEDURES
#3562TREATMENT OF A HEMATOLOGIC MALIGNANCY WITH 2-(4-CHLOROPHENYL)-N-((2-(2,6- DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE
#3563Methods of Inhibiting SARS-CoV-2 Replication and Treating Corona Virus Disease 2019
#3564Continuous administration of pharmaceutical composition for treatment of neurodegenerative disorders
#3565PHARMACEUTICAL COMPOSITION COMPRISING L-TRIIODOTHYRONINE (T3) FOR USE IN THE TREATMENT OF TISSUE HYPOXIA AND SEPSIS
#3566COMPOSITIONS AND METHODS FOR NANOPOLYMER-BASED NUCLEIC ACID DELIVERY
#3567Targeted Therapy of Kidney Fibrosis
#3568INJECTABLE OIL-BASED PHARMACEUTICAL COMPOSITION
#3569Nanoparticle vaccine adjuvant and methods of use thereof
#3570System, apparatus and method for compressing and storing data based on the amount of change in the sensed data used for state management of logistics
#3571PH20 polypeptide variants, formulations and uses thereof
#3572Lipid analogs and liposomes comprising same
#3573METHODS AND COMPOSITIONS FOR PREVENTING ADSORPTION OF THERAPEUTIC PROTEINS TO DRUG DELIVERY SYSTEM COMPONENTS
#3574Anti-TNF alpha antibody formulations
#3575COMPOSITIONS AND METHODS FOR TREATING MACULAR DYSTROPHY
#3576Methods for preventing dengue and hepatitis a
#3577Long lasting effect of new botulinum toxin formulations
#3578HMGB1 antagonist treatment of severe sepsis
#3579COMPOSITIONS AND TREATMENTS FOR ISCHEMIC INJURIES
#3580Intravenous physiological solution to optimize fluid therapy in patients
#3581Biodegradable, Antioxidant, Thermally Responsive Injectable Hydrogel and Uses Therefor
#3582Use of a nitrogen-containing bisphosphonate in combination with a glucocorticoid in preventing or treating viral pneumonia
#3583PROCESS AND THERAPEUTIC COMPOSITION FOR TREATING AND PREVENTING SEVERE INJECTION SITE REACTIONS
#3584NEUROACTIVE STEROID FORMULATIONS AND METHODS OF TREATING CNS DISORDERS
#3585METHODS OF REDUCING MORTALITY IN SUBJECTS SUFFERING FROM AN UNDERLYING DISEASE OR CONDITION BY ADMINISTRATION OF METHYLNALTREXONE
#3586METHOD TO DELIVER ANTIFIBRINOLYTIC DRUGS TO MITIGATE DAMAGE TO THE BRAIN CAUSED BY CONCUSSIVE IMPACT
#3587INHIBITORS OF THE INTERACTION OF THE UPAR/FPRS RECEPTORS
#3588CELL-RECEPTOR TARGETED EXOSOMES
#3589POROUS DOUBLE-NETWORK HYDROGEL
#3590Antibiotic formulations for lower back pain
#3591Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate
#3592Injectable and inhalable formulations
#3593LIPID EMULSIONS AND USES THEREOF
#3594PHARMACEUTICAL COMPOSITION COMPRISING NEW LACTOBACILLUS PLANTARUM KC3 STRAIN AND LEONURUS JAPONICUS EXTRACT AS ACTIVE INGREDIENTS FOR PREVENTING OR TREATING RESPIRATORY DISEASE AND USE THEREOF
#3595METHODS FOR TREATING AND FOR INHIBITING PROGRESSION OF SEIZURES
#3596DEPOT FORMULATIONS
#3597COMPOSITION COMPRISING TRABECTEDIN AND AN AMINO ACID
#3598METHODS FOR TREATING CHRONIC SPONTANEOUS URTICARIA BY ADMINISTERING AN IL-4R ANTAGONIST
#3599TREATMENT OF LOWER RESPIRATORY TRACT INFECTION WITH TRADIPITANT
#3600ISOFLAVONOID COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER